Yes, coronavirus outbreak spreads across the world.

https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases

https://www.ecdc.europa.eu/en/current-risk-assessment-novel-coronavirus-situation

https://www.bloomberg.com/news/articles/2020-03-02/u-s-deaths-rise-to-six-treatments-seen-in-months-virus-update

Yes, coronavirus outbreak spreads across the world.

https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases

https://www.ecdc.europa.eu/en/current-risk-assessment-novel-coronavirus-situation

https://www.bloomberg.com/news/articles/2020-03-02/u-s-deaths-rise-to-six-treatments-seen-in-months-virus-update

Dear Arvind Singh,

Thank you for your update regarding COVID-19. I appreciate your contribution.

Unfortunately, there are no vaccines available at the moment. For further information read the following review article:

Article The Novel Coronavirus: A Bird’s Eye View

Dear Parham,

Thank you for your kind update. I appreciate your contribution.

Now no vaccines and no drug available at this time.

https://time.com/5799718/coronavirus-vaccine-antiviral-studies/

Dear Anton,

Thank you for your update regarding corona virus.

Scientists in Israel have claimed to develop a vaccine against coronavirus.

https://economictimes.indiatimes.com/news/science/scientists-in-israel-likely-to-announce-it-developed-coronavirus-vaccine/articleshow/74592807.cms

We pray and hope the vaccine should come to fruitful Arvind.

Australian researchers claim that malaria and HIV drugs are effective in treating the coronavirus infections.

Anti-viral drug Favipiravir has been reported effective in treating coronavirus.

https://theprint.in/world/research-in-china-finds-anti-viral-drug-favipiravir-effective-in-treating-coronavirus/382599/

Till now there is no drug

Dear Balqees,

Thank you for your update.

Dear Amin,

Thank you your update. We need to wait for a while to see Australian claim.

Coronavirus (COVID-19) epidemic has a natural origin.

Article The proximal origin of SARS-CoV-2

A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the trial. KPWHRI is part of NIAID’s Infectious Diseases Clinical Research Consortium. The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks...

https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins

Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine

These therapies don’t use samples of the virus itself, as typical vaccines do (in either dead or weakened form, to jump-start the body’s natural defenses). Instead, they rely on RNA to kickstart the production of proteins similar enough to the virus that they trigger the body’s development of antibodies effective against the actual target...

https://techcrunch.com/2020/03/17/pfizer-and-biontech-announce-joint-development-of-a-potential-covid-19-vaccine/

People with blood group A have a significantly higher risk for acquiring COVID-19.

Preprint Relationship between the ABO Blood Group and the COVID-19 Su...

Almost 14 people affected in Bangladesh in 2nd week(running)

Digestive problems like diarrhoea could be the first sign of the coronavirus (COVID-19) for many patients. Please see the following PDF attachment.

China says Japan-developed drug Avigan works against coronavirus

https://asia.nikkei.com/Spotlight/Coronavirus/China-says-Japan-developed-drug-Avigan-works-against-coronavirus?fbclid=IwAR39Zivi43UTv3eX5MwSBlGYbsbTuixRop7DLlAXYt2mcbtWkRAh0Sf4tU4

mRNA-1273 vaccine by Moderna and Vaccine Research Center

Moderna and the Vaccine Research Center, a unit of the National Institute of Allergy and Infectious Diseases (NIAID), have collaborated to develop a vaccine for coronavirus. The vaccine targets the Spike (S) protein of the coronavirus.

The first vials of the vaccine have been manufactured at Moderna’s Massachusetts manufacturing plant and shipped to NIAID for phase one human clinical trial. The trial began on 16 March at the Kaiser Permanente Washington Health Research Institute in Seattle, Washington. A total of 45 males and females aged between 18 and 45 have been enrolled for the trial.

The participants will be divided into three cohorts who will be administered 25 microgram (mcg), 100mcg or 250mcg dose 28 days apart.

Source: https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/

Avian Coronavirus Infectious Bronchitis Virus (IBV) vaccine by MIGAL Research Institute

The MIGAL Research Institute in Israel announced that an Infectious Bronchitis Virus (IBV) vaccine developed to treat avian coronavirus has been modified to treat COVID-19. The vaccine has demonstrated efficacy in pre-clinical trials conducted by the Volcani Institute.

The IBV vaccine was developed after four years of research and has high genetic similarity to the human coronavirus. The institute has genetically modified the vaccine to treat COVID-19 and will be available in the oral form.

The institute is currently exploring potential partners for producing the vaccine in the next eight to ten weeks and obtaining the necessary safety approvals for in-vivo testing

Source: https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/

Dear Sadanand, thank you for your update. There is hope that already a drug there to work.

Dear Shiblur Rahman, thank you for the update. China says this drug recovered 70-80% of the symptoms. It is a hope to cope with. Traditional malaria drug also works, claimed by France scientist today (Metro newspaper, England, 20.03.2020).

Dear Md Sakhawot, thank you for your update. Bangladesh can avoid more infection if they can impose strict quarantine/isolation.

Coronavirus: How close are we to a vaccine or drug?

There are more than 20 vaccines in development. One has begun human trials after unusually skipping any animal research to test either the safety or the effectiveness of the vaccine.

Other scientists are at the animal research stage and hope to get the results of human trials later in the year.

But even if scientists can celebrate having developed a vaccine this year, there is still the massive job of being able to mass-produce it.

It means, realistically, one would not be ready until at least the middle of next year.

All of this is happening on an unprecedented timescale and using new approaches to vaccines, so there are no guarantees everything will go smoothly.

Remember there are four coronaviruses that already circulate in human beings. They cause the common cold, and we don't have vaccines for any of them...

https://www.bbc.com/news/health-51665497

According to the informations today I would be very cautious:

https://www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6742a4-H.pdf

https://pubmed.ncbi.nlm.nih.gov/7747525/

Article Measles Antibody: Reevaluation of Protective Titers

Article Universal varicella vaccination increased the incidence of h...

Article A case of respiratory toxigenic diphtheria: Contact tracing ...

Article The autoimmune/inflammatory syndrome induced by adjuvants (A...

Mogensen SW, Andersen A, Rodrigues A, Benn CS, Aaby P: The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment EBioMedicine 17 (2017) 192–198

The US National Institute of Allergy and Infectious Diseases (NIAID) and pharmaceutical company Moderna are seeking 30,000 volunteers for the largest clinical trial to date of their jointly developed COVID-19 vaccine.

Candidates for this Phase 3 trial, to be conducted at an estimated 70 sites across the US, must be at least 18 years old and currently not infected with the coronavirus. Those interested in participating can sign up on the government’s CoVPN Volunteer Screening Registry, an online system developed by Oracle...

https://www.forbes.com/sites/oracle/2020/07/28/niaid-seeks-1-million-volunteers-for-covid-19-vaccine-trials/#36570a8a86f7